OMVs - Vaccine against Pasteurellaceae
|
|
- Angelica Moore
- 6 years ago
- Views:
Transcription
1 OMVs - Vaccine against Pasteurellaceae 100 nm Stefan Schild Institute of Molecular Biosciences University of Graz
2 market potential human pathogens veterinary pathogens the vaccination market is growing :18 bn US$ in 2009, 28 bn US$ in 2018 mentality is changing towards prevention versus treatment several vaccine opportunities (human and veterinarian) for Pasteurellaceae most relevant indications: species disease vaccine burden non-typeable Haemophilus influenzae (NTHi) HACEK group otitis media, exacerbations in COPD patients, upper respiratory tract infections infective endocarditits, exacerbations in COPD patients, upper respiratory tract infections,... NONE NONE COPD: 3 million deaths in 2004, 3rd leading cause of death by 2030 (source: WHO) Haemophilus ducreyi chancroid NONE increases risk of HIV infection by 10- fold Pasteurella multocida Mannheimia haemolytica Bovine respiratory disease (BRD), pastereullosis Bovine respiratory disease (BRD), respiratory disease in cattle and sheep available, but narrow range protection available, but narrow range protection BRD: 1 bn US$ losses/ year (source: McVey, 2009 and Miles, 2009 in Anim. Health Res.) strains of species within the Pasteurellaceae are too heterogenous for a broad range vaccine
3 Outer membrane vesicles - OMVs Kuehn and Kesty, 2005 naturally released spherical structures ( nm) non-living facsimiles of the bacteria
4 OMVs as vaccine candidates Grow bacteria Harvest medium Purify OMVs Resuspend OMVs yield: 3-7 mg/l initial immunization boost boost day 0 day 14 day 28 challenge day route: intranasal (oral) dose: 25 µg/immunization (down to 0.25 µg/immunization)
5 OMVs as vaccine candidates coating antigen strain 1 coating antigen: heterologous strain IM-1 IM-2 IM-2 IM-1 co co challenge with strain 1 challenge with heterologous strain co: PBS treated mice IM-1: mice immunized with OMVs from NTHi strain 1 IM-2: mice immunized with OMVs from NTHi strains 1, 2 and 3
6 advantages of the OMV-based vaccine highly immunogenic induction of a solid, protective immune response highly immunogenic (protective immune response with <1 µg per animal) simple production simple manufacturing process with high yield (3 to 7 mg/l) easy storaging no need for cold chain stable for one year at RT no need for complex buffer solutions or adjuvants simple administration non-invasive administration (i.e. intranasal or oral) broad protection cross-strain and cross-family protection - mixtures are applicable presentation of a variety bacterial surfaceexposed antigens in their native conformation (most immunogenic antigens identified)
7 project status research status Roier S, Fenninger CJ, Leitner DR, Rechberger GN, Reidl J, Schild S Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles. International Journal of Medical Microbiology Roier S, Leitner DR, Iwashkiw J, Schild-Prufert K, Feldman MF, Krohne G, Reidl J, Schild S Intranasal Immunization with Nontypeable Haemophilus influenzae Outer Membrane Vesicles Induces Cross-Protective Immunity in Mice. PLoS One 7:e42664 Schild S, Nelson EJ, Camilli A Immunization with Vibrio cholerae outer membrane vesicles induces protective immunity in mice. Infect Immun 76: Schild S, Nelson EJ, Bishop AL, Camilli A Characterization of Vibrio cholerae outer membrane vesicles as a candidate vaccine for cholera. Infect Immun 77: Bishop AL, Schild S, Patimalla B, Klein B, Camilli A Mucosal immunization with Vibrio cholerae outer membrane vesicles provides maternal protection mediated by antilipopolysaccharide antibodies that inhibit bacterial motility. Infect. Immun. 78: Leitner DR, Feichter S, Schild-Prufert K, Rechberger GN, Reidl J, Schild S Lipopolysaccharide-modifications of a cholera vaccine candidate based on outer membrane vesicles reduce the endotoxicity and reveal the major protective antigen. Infect Immun. [Epub ahead of print] 2013 Apr 29. IP status Pending PCT patent application, filed on March 30, 2012 Publication number: WO 2012/ Priority date: April 1, 2011
8 Commercial Oppertunity & Contacts University of Graz offers Technology for licensing and commercialization collaborative future development improve immunization protocol use of OMVs as antigen delivery vehicles test OMVs in a more relevant model (human or animal) Scientific Contact Assoz.-Prof. Dr. Stefan Schild University of Graz Institute of Molecular Biosciences Humbolstrasse 50, 1st floor 8010 Graz Austria tel: stefan.schild@uni-graz.at IP & Business Development Michael Freidl University of Graz Research Management and Service Universitaetsplatz Graz Austria tel: michael.freidl@uni-graz.at
Bacterial Methylation and Role in Understanding Disease
Bacterial Methylation and Role in Understanding Disease Michael Jennings Pacific Biosciences, West Coast UGM, Stanford, December 3, 2015 Host adapted bacterial pathogens Neisseria meningitis, septicemia
More informationFranzens-Universitaet Graz, Humboldtstrasse 50, 8010 Graz. Phone: ++43 (0) Fax: ++43 (0)
Extracellular nucleases and extracellular DNA play important roles in Vibrio cholerae biofilm formation Andrea Seper 1, Vera H. I. Fengler 1, Sandro Roier 1, Heimo Wolinski 1, Sepp D. Kohlwein 1, Anne
More informationIVI and Technology Transfer. 14 th DCVMN Meeting Hanoi, October 7-9, 2013
IVI and Technology Transfer 14 th DCVMN Meeting Hanoi, October 7-9, 2013 5 17 months: 46% - 27% - 18 months 6-12 weeks: 27% - 15 % 86 / 78% IVI Vision & Mission VISION Developing countries free of suffering
More informationRole of Pre-weaning and Weaning Vaccination in Health Maintenance
Role of Pre-weaning and Weaning Vaccination in Health Maintenance W. Mark Hilton, DVM, PAS, Diplomate ABVP Beef Cattle Practice Technical Consultant, Elanco Animal Health West Lafayette, Indiana, USA w.mark.hilton@elanco.com
More informationModulation of Immune Response in Lambs
Modulation of Immune Response in Lambs A.S. Leaflet R1473 Jose O. Lopez Virella, graduate research assistant, M. L. Kaeberle, professor, veterinary microbiology Mamadou Niang, graduate research assistant.
More informationLichenase fusions improve immunological properties of antigens
Lichenase fusions improve immunological properties of antigens Konstantin Musiychuk Center for Molecular Biotechnology, Fraunhofer USA 03/27/2012 Lichenase Hydrolysis site of β-glycans Structure of the
More informationMucosal Immunity induced by VLPs
Virus-like paticles (VLPs) as vaccines, vectors and adjuvants, Fondation Mérieux, Annecy, 04 Mucosal Immunity induced by VLPs Denise Nardelli-Haefliger Lausanne University Hospital, Switzerland Purified
More informationMicrobial Biotechnology agustin krisna wardani
Microbial Biotechnology agustin krisna wardani 1. The Structure of Microbes Microbes (microorganisms) are tiny organisms that are too small to be seen individually by the naked eye and must be viewed with
More informationACVM REGISTRATION STANDARD AND GUIDELINE FOR EFFICACY OF VACCINES
ISBN 0-478-07721-1 36 ACVM 07/04 New Zealand Food Safety Authority Post Office Box 2835 Wellington, New Zealand ACVM REGISTRATION STANDARD AND GUIDELINE FOR EFFICACY OF VACCINES This document may be altered
More informationPatentability/Literature Research
Patentability/Literature Research The probiotic-based solution to combat cholera as presented here comprises of two major innovative components: (1) the metabolite-dependent pathogen inhibition by a probiotic
More informationGuidelines on the nonclinical evaluation of vaccine adjuvants and adjuvanted vaccines
Annex 2 Guidelines on the nonclinical evaluation of vaccine adjuvants and adjuvanted vaccines Introduction 61 Background 62 Scope 62 General considerations 63 Terminology 65 Part A. Manufacturing and quality
More informationNew Hope For Serious Infections
New Hope For Serious Infections Forward-Looking Statements Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning
More information1 R01 AI VMD HALFORD, W
1 R01 AI104935-01 2 VMD 1R01AI104935-01 ILLIAM CRITIQUE 1: Significance: 5 Investigator(s): 2 Innovation: 5 Approach: 8 Environment: 2 Overall Impact: This application proposes to develop a recombinant
More informationRSV vaccine development for Low and Middle Income Countries: Challenges and Progress
Global Vaccine and Immunization Research Forum RSV vaccine development for Low and Middle Income Countries: Challenges and Progress Claudio F. Lanata, MD, MPH Senior Researcher, Instituto de Investigación
More informationCharacterization of Glycoconjugate Vaccines from a Regulatory Perspective
Characterization of Glycoconjugate Vaccines from a Regulatory Perspective Willie F. Vann, Chief Laboratory of Bacterial Polysaccharides CBER/FDA Bethesda, Maryland USA Many Pathogenic Bacteria are Encapsulated
More informationOne-Step Western TM Kit using TMB
Technical Manual No. 0203 Version 03272008 I Description.. 1 II Kit Contents.. 2 III Applications 3 IV Key Features.. 3 V Storage.. 3 VI One-Step Western TM Protocol. 3 VII Examples. 3 VIII Troubleshooting..
More informationApplication Note AN001
Testing hybridoma supernatants with the Spots On Dots Antibody Screening Kit Application Note AN1 Table of Contents Overview... 2 Figure 1. Screening of hybridomas raised against peptide antigens... 3
More informationGuideline on requirements for the production and control of immunological veterinary medicinal products
14 June 2012 EMA/CVMP/IWP/206555/2010 Committee for Medicinal Products for Veterinary Use (CVMP) Guideline on requirements for the production and control of immunological veterinary Draft agreed by Immunologicals
More informationScience & Technology Directorate
Science & Technology Directorate National Center for Zoonotic & Animal Disease Defense (ZADD) - CEEZAD COE S&T Review October 2013 Dr. Juergen Richt CEEZAD Director Washington, D.C. ZADD Overview COE Description
More informationThe World Leader in SPR Technology. Jimmy Page, PhD, Biacore, Inc.
The World Leader in SPR Technology Jimmy Page, PhD, Biacore, Inc. Objectives of Biacore Experiments Yes/No Data» Is there binding?» Ligand Fishing Concentration Analysis: How MUCH? Active Concentration
More informationOUR PROGRAMS FIT YOUR MANAGEMENT PLANS.
OUR PROGRAMS FIT YOUR MANAGEMENT PLANS. Flexible Options Whether you begin your vaccination protocol at branding age, preweaning or weaning, the Market Ready TM Quality Feeder Calf Program can fit the
More informationOIE Guideline. International Reference Antibody Standards for Antibody Assays. 1. Introduction
OIE Guideline International Reference Antibody Standards for Antibody Assays 1. Introduction 1.1. Purpose This document provides guidelines for the preparation, validation and distribution of antibodies
More information1 Name. 1. (3 pts) What is apoptosis and how does it differ from necrosis? Which is more likely to trigger inflammation?
1 Name MCB 150 Midterm Eam #1 (100 points total) Please write your full name on each page of the eam!! The eam consists of 17 questions (6 pages). Each has a different point count as indicated. Please
More informationCustom Antibodies Services. GeneCust Europe. GeneCust Europe
GeneCust Europe Laboratoire de Biotechnologie du Luxembourg S.A. 2 route de Remich L-5690 Ellange Luxembourg Tél. : +352 27620411 Fax : +352 27620412 Email : info@genecust.com Web : www.genecust.com Custom
More informationStatus of Vaccine Research and Development for Nontyphoidal Salmonelloses Prepared for WHO PD-VAC
Status of Vaccine Research and Development for Nontyphoidal Salmonelloses Prepared for WHO PD-VAC I. About the Disease and Pathogen Basic information on pathogen, including transmission, estimated global
More informationThere was a reduction in number of new individuals being vaccinated / vaccine uptake was lower / higher number of babies; 1 [7]
1. (a) Antibody binds/eq/recognises only to cancer cells; because of antibody-antigen binding/eg; enzyme activates the drug; at cancer cells only; max 3 B lymphocytes produce antibodies/involved in humoral
More informationChapter 17: Immunization & Immune Testing. 1. Immunization 2. Diagnostic Immunology
Chapter 17: Immunization & Immune Testing 1. Immunization 2. Diagnostic Immunology 1. Immunization Chapter Reading pp. 505-511 What is Immunization? A method of inducing artificial immunity by exposing
More informationAGRICULTURAL RESEARCH FOUNDATION INTERIM REPORT FUNDING CYCLE
AGRICULTURAL RESEARCH FOUNDATION INTERIM REPORT FUNDING CYCLE 2016 2018 TITLE: Does Feeding Selenium-Enriched Alfalfa Hay For Eight Weeks Improve Performance And Health Of Weaned Beef Calves? RESEARCH
More informationProduct Permission Document (PPD) of Botulinum Toxin Type A for Injection Ph.Eur Purified Neurotoxin Complex
Product Permission Document (PPD) of Botulinum Toxin Type A for Injection Ph.Eur Purified Neurotoxin Complex Brand Name : BOTO GENIE 1. Introduction : BOTO GENIE (Botulinum Toxin Type A for Injection Ph.Eur)
More informationDECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT
Bundesamt für Verbraucherschutz und Lebensmittelsicherheit (BVL) Federal Office of Consumer Protection and Food Safety Mauerstraße 39-42 10117 Berlin (Germany) DECENTRALISED PROCEDURE PUBLICLY AVAILABLE
More informationE. coli and mammalian cells : most widely used
Host cells for the production of biopharmaceuticals Many of biopharmaceuticals, especially proteins : produced by recombinant DNA technology using various expression systems Expression systems : E. coli,
More informationStep-by-Step Description of ELISA
Step-by-Step Description of ELISA The protocols in this kit rely on indirect antibody capture ELISA. The steps in this assay are: Step 1: Antigen is added to the wells of the microplate strip and incubated
More informationNew Dairy Products and Value Chains
Whai Hua Primary Growth Partnership (PGP) Programme New Dairy Products and Value Chains Final Summary Report April 2017 1 Executive Summary Investment. The PGP programme New Dairy Products and Value Chains
More informationHuman Bordetella Pertussis IgG ELISA kit
Human Bordetella Pertussis IgG ELISA kit Catalog number: NR-R10157 (96 wells) The kit is designed to qualitatively detect Bordetella Pertussis IgG in Human serum or plasma. FOR RESEARCH USE ONLY. NOT FOR
More informationOIE Guideline. 1. Introduction
OIE Guideline INTERNATIONAL REFERENCE STANDARDS FOR ANTIGEN DETECTION ASSAYS 1. Introduction 1.1. Purpose This document provides guidelines for the preparation, validation and distribution of antigens
More informationPhage therapy. Institute of Molecular Biomedicine Comenius University, Faculty of Medicine
Phage therapy Institute of Molecular Biomedicine Comenius University, Faculty of Medicine www.imbm.sk tothova.lubomira@gmail.com Outline Introduction Taxonomy Cycles of phages Bacterial resistance Phage
More informationQuality Control in Biotechnology. Andrew Lees, Ph.D. Scientific Director Fina BioSolutions LLC.
Quality Control in Biotechnology Andrew Lees, Ph.D. Scientific Director Fina BioSolutions LLC www.finabio.com Fina Chemical drugs vs Biologicals Chemical drugs can be precisely defined Physical chemical
More informationDeveloping Vaccines for Neglected Diseases
Developing Vaccines for Neglected Diseases Vaccine Technologies II Albufeira, Portugal June 5 th, 2008 Douglas Holtzman, Ph.D., M.P.H. Senior Program Officer, Global Health Program Bill & Melinda Gates
More informationCourse Descriptions. BIOL: Biology. MICB: Microbiology. [1]
Course Descriptions BIOL: Biology http://www.calendar.ubc.ca/vancouver/courses.cfm?code=biol [1] BIOL 112 (3) Biology of the Cell The principles of cellular and molecular biology using bacterial and eukaryotic
More informationPasteurella multocida
BACTOTYPE PCR Amplification Kit Pasteurella multocida Labor Diagnostik Leipzig Manual Technology The product group BACTOTYPE PCR Amplification Kit comprises optimised systems for the identification of
More informationAN ELISA FOR THE DETECTION OF ANTIBODIES AGAINST NEWCASTLE DISEASE VIRUS IN AFRICAN VILLAGE POULTRY
AN ELISA FOR THE DETECTION OF ANTIBODIES AGAINST NEWCASTLE DISEASE VIRUS IN AFRICAN VILLAGE POULTRY J.G. BELL, M. LELENTA Animal Production Unit, Food and Agriculture International Atomic Energy Agency,
More informationComprehensive T cell antigen discovery using a genomic approach
Engineering Conferences International ECI Digital Archives Vaccine Technology IV Proceedings Spring 5-21-2014 Comprehensive T cell antigen discovery using a genomic approach Jessica Baker Genocea Biosciences
More informationDEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK
DEPARTMENT OF CLINICAL LABORATORY SCIENCES SCHOOL OF HEALTH TECHNOLOGY AND MANAGEMENT THE UNIVERSITY AT STONY BROOK STONY BROOK, NEW YORK 11794-8205 MICROBIOLOGY COMPETENCY EVALUATION FORM STUDENT NAME:
More informationApplied Protein Services
Applied Protein Services Applied Protein Services A Window into the Future Development risk and attrition rates remain two of the greatest challenges to a successful biopharmaceutical pipeline. To help
More informationspecial offers from your protein biology resource
special offers from your protein biology resource Pop open your cells, extract your proteins, purify, quantify and express them. Seeking knowledge about proteins with Thermo Scientific Protein Research
More informationDe-risking Vaccine Formulation Design
De-risking Vaccine Formulation Design Drug Delivery & Formulation Summit and Expo San Diego 13 June 2016 Roger H Brookes Overview Introduction TB vaccine Proof-of-Concept for antigen (H4) specific immunomodulation
More informationPassive vaccination as a global strategy for preventing RSV disease in infants. Filip Dubovsky MD MPH FAAP MedImmune March 2016
Passive vaccination as a global strategy for preventing RSV disease in infants Filip Dubovsky MD MPH FAAP MedImmune March 2016 Outline for Presentation Rationale for passive immunization for RSV prophylaxis
More informationThe Vaxonella Platform for Oral Recombinant Vaccine Delivery
The Vaxonella Platform for Oral Recombinant Vaccine Delivery Dr Rocky Cranenburgh Chief Scientific Officer Friday 26 th September 2014 4 th International Conference on Vaccines & Vaccination, Valencia
More informationInbound Material Transfer Agreement Questionnaire
This form is to be used when requesting materials using a Material Transfer Agreement (MTA). The information you provide will aid in reviewing the agreement. KU RECIPIENT SCIENTIST S INFORMATION Inbound
More informationMICROBIAL MANAGEMENT AS PART OF THE OPERATIONAL STRATEGY FOR SHRIMP FARMING DISEASE CONTROL
MICROBIAL MANAGEMENT AS PART OF THE OPERATIONAL STRATEGY FOR SHRIMP FARMING DISEASE CONTROL Peter De Schryver, PhD Project Team Leader Health Innovations Department INVE Technologies N.V. 1 DISEASES, A
More informationAnti-Asian Sea bass (Lates calcarifer) IgM monoclonal antibody labelled with horseradish peroxidase. Product no: C2-HRP
Anti-Asian Sea bass (Lates calcarifer) IgM monoclonal antibody labelled with horseradish peroxidase Product no: C2-HRP Product Description This monoclonal antibody (Mab) reacts with Asian Sea bass (Lates
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES NON-AMPLIFIABLE IN EUKARYOTIC CELLS FOR VETERINARY USE
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Veterinary Use CVMP/IWP/07/98-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS NOTE FOR GUIDANCE 1 : DNA VACCINES
More informationProfibrinolytic diabody targeting PAI-1 and TAFI for treatment of acute thrombotic disorders
ProFiDIΛ Profibrinolytic diabody targeting PAI-1 and TAFI for treatment of acute thrombotic disorders THROMBOLYSIS WITH IMPROVED SAFETY A valorisation project of Unmet Medical Need = Safe Thrombolysis
More informationAnimal Issues in Research Reproducibility
Animal Issues in Research Reproducibility Gaylen L. Edwards, DVM, PhD Animal Care and Experimentation Committee American Physiological Society College of Veterinary Medicine University of Georgia Why Should
More informationForecast diagnostics for antimicrobial resistance (AMR)
Forecast diagnostics for antimicrobial resistance (AMR) Authors: Ann Van den Bruel, Philip Turner NIHR Diagnostic Evidence Cooperative Oxford, University of Oxford Context When asked to make forecasts
More informationINTERIM RESULTS AS OF MARCH 31, 2017
INTERIM RESULTS AS OF MARCH 31, 2017 1 FORWARD-LOOKING STATEMENTS This presentation includes forward-looking statements that involve risks, uncertainties and other factors, many of which are outside of
More informationDiagnostics gathering intelligence to fight antimicrobial resistance
Diagnostics gathering intelligence to fight antimicrobial resistance Arjon van Hengel European Commission DG Research and Innovation, Health Directorate Unit "Fighting Infectious Diseases and Advancing
More information1. Cross-linking and cell harvesting
ChIP is a powerful tool that allows the specific matching of proteins or histone modifications to regions of the genome. Chromatin is isolated and antibodies to the antigen of interest are used to determine
More informationProtein Sources (Heterologous expression of proteins)
Protein Sources (Heterologous expression of proteins) Adrian Suarez Covarrubias Before starting out - why? what? when? where? Recombinant expression? if so, choice of host: prokaryote? eukaryote? modification
More informationDepartment of the Environment, Food and Rural Affairs
Department of the Environment, Food and Rural Affairs Advisory Committee on Releases to the Environment Format 2: Release of genetically modified organisms other than higher plants PART C: SUMMARY NOTIFICATION
More informationAntifungal PK/PD Made Simple. David Andes, MD University of Wisconsin
Antifungal PK/PD Made Simple David Andes, MD University of Wisconsin PK/PD Concept Serum Drug Concentration Peak:MIC AUC:MIC Ratio Time Above MIC MIC Time Hypothesis and Concept There is an optimal drug
More informationDiscovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A
Discovery and Humanization of Novel High Affinity Neutralizing Monoclonal Antibodies to Human IL-17A Contacts: Marty Simonetti martysimonetti@gmail.com Kirby Alton kirby.alton@abeomecorp.com Rick Shimkets
More informationWake Forest Baptist Medical Center Guideline for Use of Ribavirin in the Treatment of Respiratory Syncytial Virus (RSV) Infection
Wake Forest Baptist Medical Center Guideline for Use of Ribavirin in the Treatment of Respiratory Syncytial Virus (RSV) Infection General Information Aerosolized ribavirin has been shown in limited clinical
More informationImmune System. Viruses vs. Bacteria
Immune System Viruses vs. Bacteria Concept Map Section 19-1 Bacteria are classified into the kingdoms of Eubacteria Archaebacteria include a variety of lifestyles such as live in harsh environments such
More informationWAVA Update to LSDF Board
WAVA Update to LSDF Board December 7, 2010 Larry Corey WAVA Science Director Incoming President of the Fred Hutchinson Cancer Center Harlan Patterson WAVA Executive Director 1 Washington Vaccine Alliance
More informationOIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2016 This report has been submitted : 2016-12-11 14:12:34 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Avian
More informationProduct origin. Solfatara volcanic water. Sulfolobus solfataricus. The product: engineered SsoPox variant. T : about 90 C ph: 1 to 5
Product origin Solfatara volcanic water T : about 90 C ph: 1 to 5 Sulfolobus solfataricus Extremophilic Archeon Thermostable enzymes Produce SsoPox protein The product: engineered SsoPox variant PTE (Phosphotriesterase)
More informationExoGlow -NTA Fluorescent Labeling Kit
ExoGlow -NTA Fluorescent Labeling Kit Cat # EXONTA100A-1 User Manual Store kit at +4 0 C Version 1 5/16/2017 A limited-use label license covers this product. By use of this product, you accept the terms
More informationHSV-2 therapeutic vaccine program. Subunit vaccine candidates
HSV-2 therapeutic vaccine program Subunit vaccine candidates Our HSV-2 vaccine program Therapeutic subunit vaccine T-cell-based Aim: Best-in-class antigens by engineering Excellent standing (Sept 2017):
More informationAcinetobacter baumannii
PCRmax Ltd TM qpcr test Acinetobacter baumannii hypothetical protein sequence gene 150 tests For general laboratory and research use only 1 Introduction to Acinetobacter baumannii Acinetobacter baumannii
More informationPeliClass human IgG subclass ELISA kit Enzyme-linked immunosorbent assay
PeliClass human IgG subclass ELISA kit Enzyme-linked immunosorbent assay Catalog No: M1551 Size: six pre-coated 8-well strips for each of the four IgG subclasses Test description The PeliClass human subclass
More informationOverview of the animal health drug development and registration process: an industry perspective
Perspective Mini Focus: Animal Pharmaceuticals For reprint orders, please contact reprints@future-science.com Overview of the animal health drug development and registration process: an industry perspective
More informationAntibody-Mediated Immobilization of Campylobacter fetus:
INFECTION AND IMMUNITY, Apr. 1976, p. 1266-1272 Copyright X 1976 American Society for Microbiology Vol. 13, No. 4 Printed in U.S.A. Antibody-Mediated Immobilization of Campylobacter fetus: Inhibition by
More informationAcinetobacter baumannii
TM Primerdesign Ltd Acinetobacter baumannii hypothetical protein sequence gene genesig Advanced Kit 150 tests For general laboratory and research use only 1 Introduction to Acinetobacter baumannii Acinetobacter
More informationDifferent Potential of Extracellular Vesicles to Support Thrombin Generation: Contributions of Phosphatidylserine, Tissue Factor, and Cellular Origin
Different Potential of Extracellular Vesicles to Support Thrombin Generation: Contributions of Phosphatidylserine, Tissue Factor, and Cellular Origin Carla Tripisciano 1, René Weiss 1, Tanja Eichhorn 1,
More informationOIE Standard on principles and methods of validation of diagnostic assays for infectious diseases
OIE Standard on principles and methods of validation of diagnostic assays for infectious diseases OIE Regional Workshop for OIE National Focal Points for Veterinary Products Maputo, Republic of Mozambique
More informationRapid GST Inclusion Body Solubilization and Renaturation Kit
Product Manual Rapid GST Inclusion Body Solubilization and Renaturation Kit Catalog Number AKR-110 FOR RESEARCH USE ONLY Not for use in diagnostic procedures Introduction Bacteria are widely used for His
More informationB-cell Epitope Prediction and Cloning monoclonal ADAs
B-cell Epitope Prediction and Cloning monoclonal ADAs Stefan Ryser, CEO, Trellis Bioscience 3 rd International Symposium on Higher Order Structure of Protein Therapeutics Arlington, Virginia, February
More informationLTX 109. BIO International Philadelphia 2015
LTX 109 BIO International Philadelphia 2015 Lytix Biopharma company background Established in 2003 to develop and commercialize medical applications of lytic peptides originating from the University of
More informationCloning and Sequence Analysis of the 22-kDa Antigen Genes of Orientia tsutsugamushi Strains Kato, TA763, AFSC 7, , TH1814, and MAK 119
Cloning and Sequence Analysis of the 22-kDa Antigen Genes of Orientia tsutsugamushi Strains Kato, TA763, AFSC 7, 18-032460, TH1814, and MAK 119 HONG GE, a MIN TONG, a ANDREW LI, b RAJAN MEHTA, b AND WEI-MEI
More informationCOMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 25 July 2002 EMEA/ COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON THE
More informationPasteurella multocida
Techne qpcr test Pasteurella multocida Manganese-dependent superoxide dismutase (soda) 150 tests For general laboratory and research use only 1 Introduction to Pasteurella multocida Pasteurella multocida
More informationViruses. Chapter 19. Biology Eighth Edition Neil Campbell and Jane Reece. PowerPoint Lecture Presentations for
Chapter 19 Viruses PowerPoint Lecture Presentations for Biology Eighth Edition Neil Campbell and Jane Reece Lectures by Chris Romero, updated by Erin Barley with contributions from Joan Sharp Copyright
More informationSanofi Pasteur India Pvt. Ltd., Mumbai
Sanofi Pasteur India Pvt. Ltd., Mumbai S. NO. Product Name Variation Approval date and letter num 1 VAXIGRIP Strain modification - SH 2014 12-68/96-DC(Pt-1) 2/3/2014 2 Pentaxim PFS with Notifiable change:
More informationMycobacterium tuberculosis complex
TM Primerdesign Ltd Mycobacterium tuberculosis complex IS6110 repeat region genesig Advanced Kit 150 tests For general laboratory and research use only 1 Introduction to Mycobacterium tuberculosis complex
More informationInterim Technical Note The Use of Cholera Rapid Diagnostic Tests November 2016
Objective Interim Technical Note The Use of Cholera Rapid Diagnostic Tests November 2016 To provide interim guidance to Ministries of Health and other organizations on the potential use of commercially
More informationHerpes Simplex 1 IgM (HSV1 IgM)
DIAGNOSTIC AUTOMATION, INC. 23961 Craftsman Road, Suite D/E/F, Calabasas, CA 91302 Tel: (818) 591-3030 Fax: (818) 591-8383 onestep@rapidtest.com technicalsupport@rapidtest.com www.rapidtest.com See external
More informationMycobacterium tuberculosis complex. genesig Easy Kit for use on the genesig q reaction. Primerdesign Ltd
TM Primerdesign Ltd Mycobacterium tuberculosis complex genesig Easy Kit for use on the genesig q16 50 reaction For general laboratory and research use only 1 genesig Easy: at a glance guide For each DNA
More informationEAE Induction by Active Immunization in C57BL/6 Mice
Recommended protocol for use with Hooke Kit MOG 35-55/CFA Emulsion PTX (EK-0110, EK-0112, EK-0113, EK-0114, or EK-0115). Summary C57BL/6 mice develop chronic paralysis after immunization with MOG 35-55
More informationThe current status of vaccine development for control of Salmonella Paratyphi A
The current status of vaccine development for control of Salmonella Paratyphi A Rodney Carbis (Head Vaccine Development, IVI) 9 th International Conference on Typhoid and Invasive NTS Disease Bali Indonesia
More informationEAE Induction by Active Immunization in C57BL/6 Mice
Recommended protocol for use with: Hooke Kit MOG 35-55/CFA Emulsion PTX (EK-0110, EK-0112, EK-0113, EK- 0114, or EK-0115), or, Hooke Kit MOG 1-125/CFA Emulsion PTX (EK-0162 or EK-0164) Summary C57BL/6
More informationThe UspA1 Protein and a Second Type of UspA2 Protein Mediate Adherence of Moraxella catarrhalis to Human Epithelial Cells In Vitro
JOURNAL OF BACTERIOLOGY, Mar. 2000, p. 1364 1373 Vol. 182, No. 5 0021-9193/00/$04.00 0 Copyright 2000, American Society for Microbiology. All Rights Reserved. The UspA1 Protein and a Second Type of UspA2
More informationDeveloping T cell vaccines for HSV-2 Infection
Developing T cell vaccines for HSV-2 Infection Jessica Baker Flechtner, PhD World Vaccine Congress 24-26 March, 2014 Deep Pipeline of T Cell-Enabled Vaccine Candidates Discovery Pre-clinical Phase 1 Phase
More informationAssembly Biosciences Jefferies 2015 Microbiome Summit. December 16, 2015
Assembly Biosciences Jefferies 2015 Microbiome Summit December 16, 2015 Forward-Looking Statements This presentation contains forward-looking statements regarding future events. Forward-looking statements
More informationPortable breath analyser for rapid TB detection
24 Rapid Biosensor s Breath Analyser is able to detect the presence of TB bacilli in a cough deposited onto a biochemically coated sensor. TB can be indicated in only two minutes compared with hours or
More informationViruses and Bacteria Notes
Viruses and Bacteria Notes A. Virus Structure: Viruses are in contrast to bacteria. Viruses are (DNA or RNA) enclosed in a coat called a. Also some viruses have a that helps them infect their host. These
More informationAcinetobacter baumannii
TM Primerdesign Ltd Acinetobacter baumannii hypothetical protein sequence gene genesig Standard Kit 150 tests For general laboratory and research use only 1 Introduction to Acinetobacter baumannii Acinetobacter
More informationJEFFERSON COLLEGE GENERAL MICROBIOLOGY
JEFFERSON COLLEGE COURSE SYLLABUS BIO215 GENERAL MICROBIOLOGY 5 Credit Hours Prepared by: Dr. Cecil M. Hampton Revised Date: November 2005 by Dr. Ken Balak Arts & Science Education Dr. Mindy Selsor, Dean
More informationPractical Applications of Immunology (Chapter 18) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Eastern Campus
Practical Applications of Immunology (Chapter 18) Lecture Materials for Amy Warenda Czura, Ph.D. Suffolk County Community College Eastern Campus Primary Source for figures and content: Tortora, G.J. Microbiology
More information